Cardiovascular Prevention

Cardiovascular Prevention

Although the efficacy of preventive measures for the reduction of cardiovascular (CV) risk is well known, the control of risk factors in the population remains limited. The strategy commonly applied, based on CV risk stratification, is aimed at identifying individuals with significantly elevated risk level and thus more likely to derive significant benefits from pharmacological and non-pharmacological preventive measures. However, focusing on high risk individuals does not allow to achieve full normalization of risk in many subjects, because of high residual risk, i.e. a consistent degree of risk which cannot be reduced any longer because of structural alterations in target organs. Moreover, a multifactorial approach to identify subjects at risk may not only represent a significant economic burden for healthcare systems, but may also have limited success because of unsatisfactory adherence to the life style changes and the drug treatments prescribed. New technologies, including digital health and in particular mobile health tools, may offer a significant contribution for improvement in this field, specifically in primary prevention, a possibility that needs to be tested. Therefore, the task force on Cardiovascular Prevention, coordinated by Prof. Gianfranco Parati, scientific director of Istituto Auxologico Italiano, IRCCS, has two principal aims: 1) development of new integrated methods for the identification of individuals at risk, by considering a wide range of risk factors; 2) creation of new eHealth/mHealth technological instruments to support the activities of CV prevention. These objectives are pursued within the 2 research projects active in this field: the IMPROVE CVP study and the CV PREVITAL project, which are aimed at developing an innovative approach to primary cardiovascular prevention based on an eHealth/mHealth technology platform. The use of innovative digital tools within the IMPROVE CVP study and the CV PREVITAL project has the potential to allow tailoring the interventions on an individual basis, insisting on the peculiar characteristics of each subject, including psychological and socio-economic features. The results of these studies will constitute a fundamental premise for the elaboration of a national cardiovascular prevention plan aimed at an earlier intervention to more successfully fight an increased CV risk and at rationalization of limited public resources in order to make prevention affordable to a wider segment of the Italian population.

Active Projects:
  • Implementation of mobile Health and eHealth approaches for optimal cardiovascular prevention – the IMPROVE CVP study (PI: Gianfranco Parati – Istituto Auxologico Italiano)
  • Digital strategies in primary cardiovascular prevention in the italian population – CV Prevital – (PI: Elena Tremoli – Centro Cardiologico Monzino)
Coordinator:

Prof. Gianfranco Parati

Institute:

Istituto Auxologico Italiano

Partecipants:

CENTRO CARDIOLOGICO MONZINO Damiano Baldassarre – POLICLINICO SAN DONATO Alexis Malvazos – MULTIMEDICA Livio Luzi – FONDAZIONE CA’ GRANDA  Roberto Meazza – OSPEDALE SAN RAFFAELE Paolo Camici- MARIO NEGRI Carla Roncaglioni – OSPEDALE PEDIATRICO BAMBINO GESU’ Ugo Giordano – POLICLINICO SAN MATTEO Luigi Oltrona Visconti – FONDAZIONE MAUGERI Luca Chiovato – HUMANITAS Giuseppe Ferrante – SAN RAFFAELE PISANA Maurizio Volterrani – ISMETT IRCCS Alessandro Mattina – SDN Carlo Cavaliere – NEUROMED Giuseppe LEMBO – IRCCS OSPEDALE POLICLINICO SAN MARTINO Fabrizio Montecucco – MONDINO Alfredo Costa – ISTITUTO GIANNINA GASLINI – IRCCS POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI Giovanna Liuzzo